HUTCHMED (China) (HCM) Construction in Progress (2015 - 2016)
HUTCHMED (China) (HCM) posted quarterly Construction in Progress of $406000.0 for Q2 2016, down 28.4% quarter-over-quarter from $567000.0 in Q4 2015.
HUTCHMED (China) (HCM) Construction in Progress (2015 - 2016) Analysis & Trends
HUTCHMED (China) (HCM) has reported Construction in Progress for 2 consecutive years, with $406000.0 the latest figure, recorded in Q2 2016.
- In Q2 2016, Construction in Progress changed N/A year-over-year to $406000.0; the TTM figure through Jun 2016 stood at $406000.0 (changed N/A YoY), while the FY2015 annual figure was $567000.0, changed N/A from the prior year.
- Construction in Progress retreated to $406000.0 in Q2 2016 per HCM's latest filing, from $567000.0 in the prior quarter.
- Across five years, Construction in Progress topped out at $567000.0 in Q4 2015 and bottomed at $406000.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 406,000.00 |
| Dec 31, 2015 | 567,000.00 |